Vitamin K2 and D3: Protecting Women's Bones After Menopause: Osteoporosis and Osteopenia

By David S. Klein, MD, FACA, FACPM, FAAMIMS
Stages of Life Medical Institute

Quick Look
Menopause accelerates bone loss as estrogen levels decline, increasing the risk of osteopenia, osteoporosis, and fractures. Vitamin D3 helps the body absorb calcium, while vitamin K2 activates proteins involved in bone mineralization. Vitamin D Supreme by Designs for Health combines these nutrients in one formulation. Discover how nutritional support, bone-density screening, exercise, and individualized medical care work together to protect women's bones. This has been vetted for quality, purity, content, and the avoidance of soy proteins, important for patients with thyroid disease.
For many women, the first indication of osteoporosis is a fracture. Bone loss often develops silently over many years. There may be no pain, no obvious physical changes, and no warning signs until a wrist, vertebral, or hip fracture occurs.
Women are particularly vulnerable because estrogen plays an essential role in maintaining skeletal integrity.
Throughout life, bone undergoes continuous remodeling. Osteoclasts remove old bone, while osteoblasts produce new bone.
Estrogen helps maintain the balance between these processes.
When estrogen levels decline during menopause, osteoclast activity increases and bone resorption may exceed bone formation. This can produce accelerated bone loss during the early postmenopausal years.¹
Two conditions commonly emerge:
Osteopenia: Bone mineral density below the normal range, but not sufficiently reduced to meet the densitometric definition of osteoporosis.
Osteoporosis: A skeletal disorder characterized by compromised bone strength and increased susceptibility to fracture.
A DEXA scan can identify declining bone density before a fracture occurs.
Importantly, osteoporosis is not simply a calcium deficiency. Bone health depends on hormonal balance, mineral metabolism, adequate protein, physical activity, and several essential micronutrients.
Among these nutrients, vitamins D3 and K2 have attracted particular interest.
Vitamin D3: Helping Calcium Enter the Body
Vitamin D3, or cholecalciferol, is essential for normal calcium and phosphorus metabolism.
Following activation in the liver and kidneys, vitamin D supports intestinal calcium absorption and helps maintain the mineral balance necessary for skeletal mineralization.
When vitamin D levels become inadequate, calcium absorption may decline and secondary hyperparathyroidism may develop, increasing bone resorption.
Severe deficiency can also cause osteomalacia, in which newly formed bone is inadequately mineralized.
Correcting vitamin D deficiency is therefore an important part of osteoporosis management.
However, supplementation should be individualized. High doses do not necessarily provide additional skeletal benefits once vitamin D sufficiency has been achieved.²
Vitamin K2 performs a different function. Rather than increasing intestinal calcium absorption, vitamin K participates in activating proteins that regulate mineralization.
One of the most important is osteocalcin, a protein synthesized by osteoblasts.
Osteocalcin undergoes a vitamin K-dependent biochemical process called gamma-carboxylation. This modification allows it to interact with calcium-containing mineral components of bone.
Without adequate vitamin K, a greater proportion of osteocalcin remains undercarboxylated.
Vitamin K2 supplementation can improve osteocalcin carboxylation, providing evidence of its biological activity.
A second vitamin K-dependent protein, matrix Gla protein, helps regulate inappropriate mineral deposition in soft tissues.
Strontium is necessary for maintenance of bone density, and is discussed at length in another blog.
These mechanisms explain why vitamin K2 is being studied in relation to both skeletal and vascular health.
Why MK-7 Is Particularly Interesting for Osteopenia and Osteoporisis
Vitamin K2 exists in several forms, including menaquinone-4 (MK-4) and menaquinone-7 (MK-7). MK-7 has a relatively long circulating half-life, allowing sustained availability for vitamin K-dependent protein activation.
In a three-year randomized clinical trial, Knapen and colleagues reported favorable changes in certain measures of bone loss among healthy postmenopausal women receiving 180 mcg of MK-7 daily.³
However, other trials have produced less favorable findings. Although the biochemical effects of MK-7 are well established, evidence that nutritional-dose supplementation consistently reduces fractures remains insufficient.
For this reason, vitamin K2 should be viewed as a potential nutritional adjunct rather than an established osteoporosis treatment, that is, it is under aggressive current clinical evaluation.

Why Vitamin D3 and K2 Are Often Combined to treat osteoporosis and osteopenia
Vitamin D3 and vitamin K2 support different aspects of mineral metabolism.
Nutrient | Primary physiological contribution |
Vitamin D3 | Facilitates intestinal calcium and phosphorus absorption |
Vitamin K2 | Supports activation of osteocalcin and other vitamin K-dependent proteins |
Calcium | Provides mineral substrate for bone |
Magnesium | Participates in mineral metabolism and cellular enzymatic functions |
Protein | Provides the structural matrix upon which bone mineral is deposited |
Their complementary functions provide a biologically plausible rationale for combined supplementation. Nevertheless, the combination has not been established as superior to appropriate standard care for preventing osteoporotic fractures.
Featured Nutritional Support: Vitamin D Supreme, by Designs for Health
Vitamin D Supreme is a high-potency nutritional supplement combining vitamin D3 with vitamin K2 in the MK-7 form.
The product is designed to support normal calcium metabolism and vitamin K-dependent physiological processes.
What's Inside MegaQuin K2+D3?
Each capsule contains:
Active ingredient | Amount |
Vitamin D3 (cholecalciferol) | 5,000 IU (125 mcg) |
Vitamin K2 | 2000 mcg |
The manufacturer uses a fermentation-derived form of MK-7 and identifies the product as soy-free, dairy-free, gluten-free, and non-GMO.
Most other K-2 MK-7 products are soy-derived, and this is a potential problem for any person with thyroid issues, due to isoflavone content of soy-protein derivatives.
The manufacturer's suggested use is one capsule daily with a meal or as directed by a healthcare practitioner.

Key Advantages
D3 + K1/K2 Synergy: According to Designs for Health, vitamin D3 supports calcium absorption, while vitamins K1 and K2 (MK-4) help direct calcium toward bones and teeth rather than arteries and soft tissue.
Higher-Potency Maintenance Dose: Provides 5,000 IU of vitamin D3 (cholecalciferol) per capsule, which is suited for individuals with low baseline levels, limited sun exposure, or higher repletion needs as advised by a healthcare practitioner.
Added Geranylgeraniol (GG): Includes 5 mg of trans-geranylgeraniol (GG-Gold®), a naturally produced compound that declines with age and supports bone health and the body's natural vitamin K2/MK-4 pathways.
Immune and Cardiovascular Support: Formulated to support healthy immune system balance alongside arterial elasticity and cardiovascular function.
Simple Once-Daily Capsule Format: Delivers the full serving in a single capsule, typically taken with a meal containing fat to aid absorption of fat-soluble vitamins.
(Note: Because vitamin K interacts with certain medications—such as blood thinners—and 5,000 IU/day is a higher dose than standard daily minimums, checking blood levels and consulting a healthcare provider is recommended before starting.)
Why This Combination May Appeal to Women Concerned About Bone Health
Vitamin D Supreme brings together two nutrients involved in complementary aspects of skeletal mineral metabolism.
Its K-2 component supports vitamin K-dependent protein activation, while vitamin D3 helps maintain calcium absorption.
This may make the formulation a convenient option for appropriately selected women who need vitamin D supplementation and wish to include vitamin K2 in their nutritional program.
Product selection and dosing should take into account baseline vitamin D status, other supplements, calcium metabolism, kidney function, and medications. The dosage of Vitamin D may be adjusted by your physician, based upon Serum Vitamin D-3 levels. These should be monitored, at a minimum of annually, and in older patients, vitamin d levels may be monitored far more frequently.
Vitamin D Supreme is not an FDA-approved treatment for osteoporosis and should not replace medications shown to reduce fracture risk.
Clinical Pearl: Bone Density Is Not the Same as Bone Strength
Bone mineral density is an important predictor of fracture risk, but it is not the only determinant.
A woman with osteopenia may have a relatively low short-term fracture risk, while another woman with a similar T-score may have a substantially greater risk because of age, previous fractures, glucocorticoid exposure, or other conditions.
The goal of treatment is not simply to improve a DEXA score.
The goal is to prevent fractures, preserve mobility, and maintain independence. This distinction is especially important when evaluating supplements. A favorable change in a biochemical marker does not necessarily translate into fewer fractures.
Estrogen, Osteoporosis, and the Limits of Supplementation
One of the most important causes of accelerated bone loss in women is declining estrogen.
Estrogen deficiency increases osteoclast-mediated bone resorption and alters the balance between bone formation and breakdown. For appropriately selected women, menopausal hormone therapy can reduce bone loss and fracture risk.
However, hormone therapy is not suitable for everyone. Decisions must consider menopausal symptoms, age, time since menopause, cardiovascular and thromboembolic risks, cancer history, and other contraindications.
Vitamin K2 and D3 do not replace estrogen's regulatory effects on bone remodeling. Women with established osteoporosis or high fracture risk may require proven therapies, including bisphosphonates, denosumab, or anabolic medications. Nutritional support should complement—not delay—appropriate medical treatment.⁴
What Your Doctor May Evaluate Before
Recommending Supplements
At Stages of Life Medical Institute, we believe bone loss should prompt consideration of the factors responsible for its development.
Depending on the patient's circumstances, evaluation may include:
DEXA scanning: To determine bone mineral density at the hip and lumbar spine.
FRAX assessment: To estimate fracture probability and guide treatment decisions.
25-hydroxyvitamin D: To identify deficiency or assess higher-dose supplementation.
Serum calcium and kidney function: To evaluate mineral metabolism and supplementation safety.
Parathyroid hormone: When secondary hyperparathyroidism or primary parathyroid disease is suspected, best checked annually for younger patients, every 3-6 months for post menopausal women, patients with autoimmune thyroid disease, and in patient with eGFR under 60.
Thyroid function: To identify thyroid abnormalities or excessive thyroid hormone replacement. This evaluation should include monitoring for autoimmune thyroid disorders
Medication review: To identify drugs associated with accelerated bone loss.
In selected patients, further investigation may identify malabsorption, inflammatory disorders, nutritional deficiencies, or other secondary causes of osteoporosis.

A Comprehensive Strategy for Stronger Bones
No single nutrient can replace the multiple physiological systems required to maintain skeletal integrity.
An effective bone-health program should include adequate calcium intake, sufficient vitamin D, appropriate protein consumption, progressive resistance exercise, weight-bearing activity, balance training, and fall prevention.
For women over 50, approximately 1,200 mg of total daily calcium intake from food and supplements combined is commonly recommended.⁵
When osteoporosis is present, fracture-risk assessment should determine whether pharmacological therapy is indicated.
Vitamin K2 may be considered as an additional nutritional component, with the understanding that its effects on fracture outcomes remain uncertain.
Frequently Asked Questions
1. Can vitamin K2 reverse osteoporosis?
There is insufficient evidence that nutritional-dose vitamin K2 reverses established osteoporosis. It should not replace medications with demonstrated fracture-prevention benefits.
2. Can vitamin K2 help women with osteopenia?
Vitamin K2 supports normal bone-related protein activation. Whether supplementation reliably prevents progression from osteopenia to osteoporosis remains uncertain.
3. Why combine vitamin K2 with vitamin D3?
Vitamin D3 supports calcium absorption, while vitamin K2 activates proteins involved in mineralization. Their functions are complementary, although the clinical benefits of combining them are not fully established.
4. Is Vitamin D Supreme appropriate for every postmenopausal woman?
No. Its vitamin D3 dose is relatively high, and the need for supplementation should be assessed individually.
5. Can vitamin K2 help prevent arterial calcification?
Vitamin K-dependent proteins participate in regulating vascular mineralization, but clinical evidence has not established that K2 supplements prevent cardiovascular events.
6. Can women taking blood thinners use vitamin K2?
Women taking warfarin or other vitamin K antagonists should not begin vitamin K2 supplementation without medical supervision. Vitamin K intake can alter anticoagulation control.
7. How long does it take to improve bone density?
Bone remodeling is a slow process. When monitoring osteoporosis treatment, repeat DEXA measurements are commonly obtained after approximately one to two years, depending on clinical circumstances.
NOTE: please read our blogs on the use of Strontium for the treatment and prevention of osteoporosis. This is dose-related, based upon age of the patient.
Bottom Line
For women approaching or passing through menopause, preserving bone strength is an important component of healthy aging. Vitamin D3 helps maintain normal calcium absorption, while vitamin K2 supports activation of proteins involved in bone mineralization.
Vitamin D Supreme by Designs for Health, provides these complementary nutrients in a convenient formulation and may have a place in an individualized nutritional program.
However, effective osteoporosis prevention and treatment require more than supplements. Bone-density screening, hormonal and metabolic evaluation, appropriate exercise, adequate nutrition, and evidence-based medical therapy remain essential.
Healthy bones help preserve the mobility, independence, and quality of life that women deserve throughout aging.
Continue Your Journey to Better Health
At Stages of Life Medical Institute, we believe symptoms rarely occur in isolation. Bone health reflects the interaction of hormones, nutrition, mineral metabolism, kidney function, and the aging process. Understanding these relationships is essential to meaningful prevention.
Explore these related topics in our educational library:
Strontium and Osteoporosis: The potential role of strontium in bone health and why changes in bone-density measurements require careful interpretation.
Hormone Replacement Therapy and Osteoporosis: How estrogen influences bone remodeling and fracture prevention.
Vitamin D and Kidney Health: Why kidney function matters in vitamin D activation and calcium regulation.
Vitamin K: The differences between vitamin K1 and K2 and their physiological roles.
Magnesium Deficiency: Why magnesium matters in mineral metabolism and overall health.
What Is a Vitamin? Understanding the essential micronutrients that support normal physiological function.
Become a Patient
At Stages of Life Medical Institute, we combine conventional medical diagnosis with individualized nutritional, hormonal, and metabolic evaluation.
Our goal is to identify the factors contributing to bone loss and develop a comprehensive plan that supports long-term health.
Stages of Life Medical Institute
1917 Boothe Circle
Longwood, Florida 32750
407-679-3337
Teamwork Matters.
Medical References
LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33:2049–2102. PubMed.
National Institutes of Health, Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. NIH.
Knapen MHJ, Drummen NEA, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24:2499–2507. PubMed.
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:1595–1622. PubMed.
National Institutes of Health, Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals. NIH.
Huang ZB, Wan SL, Lu YJ, Ning L, Liu C, Fan SW. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials. Osteoporos Int. 2015;26:1175–1186. PubMed.
Microbiome Labs. MegaQuin K2+D3. Official manufacturer formulation and product information. Microbiome Labs.
Medical Disclaimer: This material is intended for patient education and does not replace individualized medical advice. Dietary supplements are not substitutes for established medical treatments for osteoporosis. Consult your physician before beginning supplementation, particularly when taking anticoagulants or receiving treatment for disorders of calcium metabolism.
The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances.
1917 Boothe Circle, Suite 171
Longwood, Florida 32750
Tel: 407-679-3337
Fax: 407-678-7246
© 2026 Stages of Life Medical Institute. All rights reserved.










.webp)
Comments